ENFERMEDADES HEPÁTICAS
Clínica Universitaria de Navarra
Pamplona, EspañaPublications en collaboration avec des chercheurs de Clínica Universitaria de Navarra (10)
2021
-
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
Hepatology, Vol. 73, Núm. 6, pp. 2380-2396
2014
2013
2010
2009
-
Amphiregulin Induces the Alternative Splicing of p73 Into Its Oncogenic Isoform ΔEx2p73 in Human Hepatocellular Tumors
Gastroenterology, Vol. 137, Núm. 5
-
The epidermal growth factor receptor: A link between inflammation and liver cancer
Experimental Biology and Medicine
-
Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy
Cancer Research, Vol. 69, Núm. 4, pp. 1358-1367
2008
-
The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis
Hepatology, Vol. 48, Núm. 4, pp. 1251-1261
2006
-
Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger
Hepatology, Vol. 43, Núm. 2, pp. 266-275
2004
-
Mecanismos moleculares en la formación de la bilis
Gastroenterologia y Hepatologia